To identify the prognostic value of JMJD6 expression in tumor stromal cells, tumor tissues from 109 ovarian cancer patients and 97 lung cancer patients were collected and classified according to their JMJD6 expression in stromal cells as low, medium, and high expression groups. This evidence concerns the gene JMJD6 and lung carcinoma.